|
|
||||||||||
|
J Am Coll Cardiol, 2003; 42:811-813, doi:10.1016/S0735-1097(03)00841-6 © 2003 by the American College of Cardiology Foundation |
* From the Cardiovascular Research Institute, Washington Hospital Center, Washington, DC 20010, USA
* Reprint requests and correspondence: Dr. Neil J. Weissman, Cardiovascular Research Institute, Washington Hospital Center, 110 Irving Street, NW, Suite 4B-1, Washington, DC 20010, USA.
Neil.J.Weissman{at}medstar.net
Although the concept of vascular remodeling was revolutionary, it had little effect on clinical practice in the years immediately after its publication. By its nature (necropsy), it was observational. It is also very difficult for an autopsy study to discern cause from effect (i.e., was the plaque accumulation causing the artery to expand or was plaque accumulating in those areas because there was arterial enlargement?). Most importantly, this phenomenon could not be "seen" in clinical practice. Clinical assessment of coronary arteries utilizes angiography, which outlines the luminal contour and does not allow assessment of the plaque nor of the true arterial size (other than by inference from the luminal contours). If vascular remodeling could not be confirmed in vivo and if practicing angiographers were not able to "see" the remodeling for themselves, it would have been a slow uphill battle before final acceptance of these phenomena.
Intravascular ultrasound (IVUS) circumvents those limitations. It allows in vivo, real-time assessment of the lumen, plaque, and arterial (external elastic membrane [EEM]) areas. Most importantly, IVUS is performed by angiographers and allows side-by-side comparison of the angiographic and ultrasound images. Immediately after inception of IVUS in the clinical arena, it became apparent that there is significant angiographically silent atherosclerotic disease, in part because vascular remodeling itself is "angiographically silent." Early IVUS studies replicated Glagov's observations in peripheral and coronary arteries (2). In addition to assessing the relationship between arterial size and plaque accumulation across patients, IVUS allowed the examination of focal areas of arterial expansion associated with focal accumulation of plaque. A remodeling index was developed which compares the arterial area at the reference or references to the arterial area at the lesion (3).
Intravascular ultrasound also extended the concept of vascular remodeling beyond the Glagovian compensatory enlargement. By comparing arterial lesion sites to adjacent reference sites, focal luminal narrowing (or negative remodeling) was observed. This demonstrated that luminal stenosis can also be due to arterial shrinkage in addition to atherosclerotic plaque accumulation. A remodeling index (lesion arterial area/reference arterial area) >1 indicates positive remodeling (enlargement), and a remodeling index <1 indicates negative remodeling. Positive remodeling has been associated with acute (vs. stable) coronary syndromes, and negative remodeling has been associated with smoking, insulin-dependent diabetes, and fibro-calcific disease (47). Differential remodeling in distinct populations further reinforces the likelihood that this phenomenon is real.
Ultimately, seeing is believing. Intravascular ultrasound provides immediate, visual evidence to the interventional cardiologists indicating which lesions have an arterial area larger (or smaller) than the adjacent reference. Numerous publications have documented patient characteristics and clinical conditions associated with a particular type of remodeling (47). Remodeling has even been reported in arterialized saphenous vein grafts (8). Furthermore, arterial remodeling is a dynamic phenomenon that takes place alongside atherosclerotic plaque development, with early, softer plaques causing positive remodeling and older, harder plaques associated with negative remodeling (57). It is fair to conclude that the process of vascular remodeling is now well ingrained into our concept of coronary anatomy and pathophysiology.
So why do we need yet another study on vascular remodeling? Although the evidence is rapidly mounting to support the concept of arterial remodeling, there remain some very important gaps of knowledge. All too many times, "well accepted principles" were not ultimately supported by definitive trials.
What will it take to have definitive proof that arterial remodeling occurs? There are at least two major areas of deficiencies for which we need data: 1) current cross-sectional methods of assessing remodeling assume that there is no remodeling in the reference segment, with all the remodeling occurring in the lesion segment; and 2) there are virtually no longitudinal data (other than case reports or small series [9]) demonstrating a change in arterial size in response to a change in plaque over time.
| References segment disease |
|---|
|
|
|---|
The study by Hong et al. (11) in this issue of the Journal puts this vexing issue to rest. By capitalizing on a subset of Korean patients with very little diffuse atherosclerotic disease, these investigators identified focal lesions with minimal reference segment disease (mean of 14% plaque burden). By including patients without substantial reference segment disease, they avoided the potential confounding effects of reference segment remodeling. In their subgroup, 48% demonstrated negative remodeling and 26% demonstrated positive remodeling. The remaining 26% had "intermediate" remodeling (which may represent no remodeling). This study provides two important aspect to our understanding of remodeling: 1) it further supports the concept of remodeling as a real phenomenon and proves that remodeling is not just an "artifact" of reference segment disease; and 2) it provides support that there is a higher prevalence of negative remodeling than previously appreciated (especially among patients with minimal atherosclerotic disease in their non-lesion segments). If minimal diffuse disease is a marker of early disease formation, this study implies that negative remodeling may be an early manifestation of atherosclerotic pathogenesis for (at least) some lesions. This is opposite to conventional teaching in which the early, soft lesions are associated with positive remodeling and older, hard lesions with negative remodeling (57). Consequently, as in so many other important studies, Hong et al. (11) clarify one issue (i.e., remodeling is not a methodological artifact) and question another conventional concept (i.e., that arteries exhibit positive remodeling early in the process of plaque formation). Unfortunately, neither the study of Hong et al. (11) nor any other current IVUS study can definitively address which comes first, positive or negative remodeling. The fundamental problem with IVUS studies to date is that they represent a cross-sectional observation of several patients at one point in time and infer vascular changes by comparing the lesion to the reference segment.
| The future: longitudinal IVUS studies |
|---|
|
|
|---|
Most importantly, longitudinal studies may identify unique patient characteristics and treatment strategies that are associated with favorable, positive remodeling which maintains lumen dimensions and prevents luminal obstruction. Eventually, longer term studies will be necessary to answer important questions regarding the relationship between remodeling and patient outcomes. For example, are lesions with positive remodeling more likely to rupture and be associated with an acute coronary syndrome, or has that conclusion been the result of selection bias from retrospective studies?
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Hartmann, C. von Birgelen, G. S. Mintz, P. M.J. Verhorst, and R. Erbel Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (>=12 months) follow-up Eur. Heart J., August 1, 2006; 27(15): 1778 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schoenhagen, E. M. Tuzcu, C. Apperson-Hansen, C. Wang, K. Wolski, S. Lin, I. Sipahi, S. J. Nicholls, W. A. Magyar, A. Loyd, et al. Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) Trial Circulation, June 20, 2006; 113(24): 2826 - 2834. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |